GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Autodesk, Inc. (ADSK) [hlAlert]

Rating:
Outperform
ADSK
down 8.47 %

Autodesk, Inc. (ADSK) rated Outperform with price target $64 by Burke & Quick

Posted on: Tuesday,  Jun 17, 2014  12:00 AM ET by Burke & Quick

Burke & Quick rated Outperform Autodesk, Inc. (NASDAQ: ADSK) on 06/17/2014, when the stock price was $54.63. Since
then, Autodesk, Inc. has lost 8.48% as of 11/20/2015's recent price of $50.00.
If you would have followed this Burke & Quick's recommendation on ADSK, you would have lost 8.47% of your investment in 521 days.

Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson?s disease, and ACP-104 and ACP-103, both for the treatment of schizophrenia.

Burke & Quick
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/17/2014 12:00 AM Buy
None
54.63 64.00
as of 10/17/2014
1 Week down  -5.45 %
1 Month down  -7.46 %
3 Months down  -8.35 %
1 YTD down  -7.02 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy